Maiwald Magazine

News and Releases

Maiwald Blog

26 May 2025 - Maiwald Blog

Turn one into several – what Rule 80 EPC says about using several independent claims to defend one independent claim

The Board of Appeal of the EPO has issued two decisions concerning appeal cases T 0123/22 and T 1191/22, which relate to the interpretation of Rule 80 EPC. The fundamental que...

Continue reading

11 Apr 2025 - Maiwald Blog

EPO Board of Appeal 3.3.04 is setting the right standard for acknowledging novelty of non-medical use claims (T 1913/21)

G 2/88 provides legal assessment for novelty of a non-medical use claim. G 2/88 allows acknowledging novelty of a non-medical use claim of an old compound for a particular pur...

Continue reading

8 Apr 2025 - Maiwald Blog

EPO revokes Roche’s Patent on combination therapy of bevacizumab and paclitaxel for platinum-resistant ovarian cancer that was supported by results of Phase III AURELIA clinical trial

European Patent EP 2 825 558 concerns a combination therapy of bevacizumab and paclitaxel for platinum-resistant ovarian cancer. The claim was supported by Phase III AURELIA c...

Continue reading

All articles

Press Coverage

9 Jul 2025 - Press Coverage

EP 3 996 688 Maintained as Granted: Maiwald successfully defends Formulation Patent for Tepotinib

We are happy to report that we successfully defended Merck’s formulation patent EP 3 996 688 for c-Met inhibitor Tepotinib (TEPMETKO®) in opposition proceedings at the hearing on July 9, 2025. The patent is upheld as granted.

Continue reading

9 Jul 2025 - Press Release

Royalty Pharma and Revolution Medicines Sign Funding Agreements Worth Up to $2 Billion

Royalty Pharma plc and Revolution Medicines, Inc. have announced a strategic funding collaboration of up to $2 billion to support the global development and commercialization of Revolution’s RAS(ON) inhibitor portfolio, particularly the clinical advancement of lead candida...

Continue reading

24 Jun 2025 - Press Coverage

Maiwald Advises Royalty Pharma on $2 Billion Funding Agreement with Revolution Medicines

Maiwald acted as legal advisor to Royalty Pharma in connection with an innovative funding agreement totaling up to $2 billion with Revolution Medicines. The transaction includes up to $1.25 billion in synthe...

Continue reading

Maiwald in the press

Staff News

1 Jul 2025 - Staff News

Maiwald appoints Alexander Feil, Dr. Johannes Scholz and Dr. Fabian Wiescher as Counsel

With effect from 1 July 2025, Maiwald, one of Germany's leading intellectual property law firms, has appointed Alexander Feil, Dr. Johannes Scholz and Dr. Fabian Wiescher as C...

Continue reading

4 Feb 2025 - Staff News

Maiwald congratulates Dr. Anna Closs on passing the exam

We congratulate Dr. Anna Closs on passing the German patent attorney examination!

Continue reading

8 Jan 2025 - Staff News

Maiwald appoints Dr. Lukas Delvos and Dr. Jian Sun as Counsel

Effective January 1, 2025, Maiwald, one of Germany's leading intellectual property law firms, appointed two new Counsel, Dr. Lukas Delvos and Dr. Jian Sun. Lukas Delvos until ...

Continue reading

Staff News

Publications

11 Jun 2025 - Publication

Managing IP Awards interview: Maiwald
ManagingIP June 10, 2025

In their recent feature with Managing IP, senior representatives from Maiwald – Dr. Anja Fux, Dr. Derk Vos, Heike Roeder-Hitschke, Dr. Nils Braun and Martina Boidol...

Continue reading

30 Apr 2025 - Publication

Safe Harbor Provision in European Patent LawThe Research & Bolar Exemptions, AIPLA Chemical Practice Chronicles Newsletter, Volume 13 Issue 1 2025

This article covers the most recent developments regarding the European Research Exemption, which permits the use of patented inventions for research purposes, as well as the ...

Continue reading

30 Apr 2025 - Publication

The ‘long-arm’ of the Unified Patent Court – New developments in European cross-border patent litigation, AIPLA Chemical Practice Chronicles Newsletter, Volume 13 Issue 1 2025

The jurisdictional reach of the Unified Patent Court (UPC) was a widely and controversially discussed topic from the outset. Some practitioners took the view that the UPC also...

Continue reading

All publications

Awards

30 Jun 2025 - Award

2025 IP Stars Patent Rankings in the categories “Patent Prosecution” and “Patent Disputes” revealed

We are delighted to have been honoured once again by Managing IP (MIP) as a "Top Tier Firm" in the 2025 IP Stars Patent Ranking. With awards in the categories of "Patent Prose...

Continue reading

25 Jun 2025 - Award

Dr. Marco Stief honoured as Thought Leader Germany, Lexology Index 2025

We are delighted that our colleague Dr. Marco Stief has once again been recognized as one of the leading practionee...

Continue reading

20 Jun 2025 - Award

Leaders League Ranking Germany 2025

We are delighted that Maiwald has once again been recognised in four categories in this year's Leaders League Ranking 2025:

Continue reading

All awards

Events

Wed.

21

21 May 2025 |Past Event|External Events

C5’s 18th Annual Forum on “Pharma & Biotech Patent Litigation in Europe” in Amsterdam

We are pleased that Dr. Eva Ehlich was an expert at the 18th C5 Communications Forum on “Pharma & Biotech Patent Litigation in Europe” in Amsterdam. Eva gave a presentation on “Plausibility and Post-Publication Evidence in Inventive Step ...

Continue reading

Tue.

20

20 May 2025 |Past Event|LectureVortag Live

Joint symposium with Oblon in Tokyo on May 20, 2025

The Oblon and Maiwald firms were pleased to host a complimentary joint international symposium on:U.S. and European Patent Practice: Important Aspects for Practitioners At the 2025 joint symposium, selected current aspects of protecting innovations in the U.S. and Europe were examined, considering bo...

Continue reading

Sat.

17

17 May 2025 |Past Event|External Events

Maiwald at INTA’s 2025 Annual Meeting in San Diego

The International Trademark Association's (INTA) Annual Meeting took place in San Diego from May 17 to 21 this year. Maiwald was among the many companies and law firms in attendance, represented by Susanna Heurung,

Continue reading

Thu.

15

15 May 2025 |Past Event|SeminarSeminar

Maiwald Seminar on May 15

Patent law news: EPO case law, software and UPC (Lectures will be held in German) On May 15, we had the pleasure of hosting another Maiwald seminar in our office. Thank you to the speakers and everyone involved for making this an interesting afternoon and ensuring the event ran smoothly.

Continue reading

All events